Skip to main content
. 2019 Oct 4;104(11):2144–2154. doi: 10.3324/haematol.2018.208603

Figure 1.

Figure 1.

Targets of currently approved (black) and investigated (gray) novel agents. CLL: chronic lymphocytic leukemia; BCR: B-cell receptor. This figure was produced by M. Fürstenau using servier medical art (smart.servier.com).